Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54e65afc3bec220980be2a4ced7dca4b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1796 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d234ef0da2e03e7a157e2b3662c7ac98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6128e77d6707251f2758a319facb807f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcccb011a75ffac7ab2f57fdacd5ed34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c255abc0a4f9056935ac7d95933c3a4 |
publicationDate |
2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-113692284-A |
titleOfInvention |
Relaxin receptor 1 for the treatment and prevention of heart failure |
abstract |
The present invention relates to polynucleotides comprising an expressible nucleic acid sequence encoding a relaxin family peptide Receptor (RXFP) polypeptide for use in the treatment and/or prevention of heart failure in a subject. The invention further relates to vectors comprising the polynucleotides of the invention for use in the treatment and/or prevention of heart failure, as well as host cells, RXFP agonists, kits and devices related thereto. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114249835-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114249835-A |
priorityDate |
2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |